6.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Precedente Chiudi:
$5.90
Aprire:
$6.03
Volume 24 ore:
3.71M
Relative Volume:
1.10
Capitalizzazione di mercato:
$1.51B
Reddito:
$386.15M
Utile/perdita netta:
$-56.39M
Rapporto P/E:
-27.00
EPS:
-0.23
Flusso di cassa netto:
$-55.19M
1 W Prestazione:
+3.85%
1M Prestazione:
+2.81%
6M Prestazione:
+66.94%
1 anno Prestazione:
+18.51%
Ardelyx Inc Stock (ARDX) Company Profile
Nome
Ardelyx Inc
Settore
Industria
Telefono
510-745-7047
Indirizzo
34175 ARDENWOOD BLVD., FREMONT, CA
Confronta ARDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ARDX
Ardelyx Inc
|
6.21 | 1.43B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Ripresa | Raymond James | Strong Buy |
| 2025-06-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-03-07 | Ripresa | Ladenburg Thalmann | Buy |
| 2025-03-04 | Iniziato | BTIG Research | Buy |
| 2024-11-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-07-02 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-04-05 | Iniziato | Leerink Partners | Outperform |
| 2023-12-18 | Iniziato | Raymond James | Strong Buy |
| 2023-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-08-25 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-03-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-11-17 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-05-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-12-01 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2021-10-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2021-07-21 | Downgrade | Jefferies | Buy → Hold |
| 2021-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-07-20 | Downgrade | Wedbush | Outperform → Neutral |
| 2021-03-23 | Iniziato | Wedbush | Outperform |
| 2021-01-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-20 | Ripresa | Citigroup | Buy |
| 2020-02-18 | Ripresa | Jefferies | Buy |
| 2020-02-12 | Iniziato | Citigroup | Buy |
| 2020-02-10 | Iniziato | Cowen | Outperform |
| 2019-04-08 | Iniziato | Piper Jaffray | Overweight |
| 2018-08-24 | Iniziato | Jefferies | Buy |
| 2018-03-19 | Ripresa | Leerink Partners | Outperform |
| 2017-11-29 | Reiterato | Citigroup | Buy |
| 2017-11-22 | Reiterato | Ladenburg Thalmann | Buy |
| 2017-10-17 | Ripresa | Leerink Partners | Outperform |
| 2016-03-31 | Iniziato | Ladenburg Thalmann | Buy |
| 2016-03-09 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-03 | Iniziato | Citigroup | Buy |
Mostra tutto
Ardelyx Inc Borsa (ARDX) Ultime notizie
Ardelyx, Inc.'s (NASDAQ:ARDX) Path To Profitability - simplywall.st
Ardelyx stock price target raised to $16 from $15 at Raymond James - Investing.com Australia
Should You Allocate More Funds to Kesar Enterprises Limited in YEARDay Trading Setups & Free Popular Stock Picks Selection - earlytimes.in
Aug Swings: Will Ardelyx Inc stock benefit from AI adoptionTrade Volume Summary & Accurate Intraday Trading Signals - moha.gov.vn
Marshall Wace LLP Raises Stock Position in Ardelyx, Inc. $ARDX - MarketBeat
Ardelyx, Inc. $ARDX Shares Sold by Two Seas Capital LP - MarketBeat
Stonepine Capital Management LLC Acquires New Stake in Ardelyx, Inc. $ARDX - MarketBeat
What catalysts could drive Ardelyx Inc. stock higherJuly 2025 Action & Precise Swing Trade Entry Alerts - Newser
Can Ardelyx Inc. stock rebound after recent weaknessEarnings Performance Report & Risk Controlled Stock Pick Alerts - Newser
Why Ardelyx Inc. stock could see breakout soon2025 Trading Volume Trends & Precise Trade Entry Recommendations - Newser
Ardelyx (ARDX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Can Ardelyx Inc. stock maintain operating marginsPortfolio Value Report & AI Powered Market Trend Analysis - Newser
ARDX SEC FilingsArdelyx 10-K, 10-Q, 8-K Forms - Stock Titan
Irritable Bowel Syndrome (IBS) Treatment Market Competition Analysis 2025: How Players Are Shaping Growth - EIN News
Capital Fund Management S.A. Boosts Position in Ardelyx, Inc. $ARDX - MarketBeat
Ardelyx Inc. Reports Strong Q3 Earnings Growth - MSN
Can Ardelyx Inc. stock surprise with earnings upsideWeekly Trade Recap & High Accuracy Investment Entry Signals - Newser
Will Ardelyx Inc. (41X) stock keep high P E multiplesInsider Selling & Expert-Curated Trade Recommendations - Newser
Is Ardelyx Inc. (41X) stock overpriced at current multiplesAnalyst Upgrade & Proven Capital Preservation Methods - Newser
Fundamentals Check: Is Ardelyx Inc 41X stock overpriced at current multiples2025 Bull vs Bear & Weekly High Return Forecasts - BỘ NỘI VỤ
Aug Catalysts: How Ardelyx Inc 41X stock reacts to fiscal policiesQuarterly Risk Review & Verified High Yield Trade Plans - BỘ NỘI VỤ
Virtus Investment Advisers LLC Purchases 50,946 Shares of Ardelyx, Inc. $ARDX - MarketBeat
Will Ardelyx Inc. stock deliver strong dividend growthJuly 2025 Decliners & Real-Time Volume Analysis Alerts - moha.gov.vn
Universal Beteiligungs und Servicegesellschaft mbH Cuts Holdings in Ardelyx, Inc. $ARDX - MarketBeat
Ardelyx (ARDX) Q3 2025 Earnings Call Transcript - Nasdaq
How Ardelyx Inc. (41X) stock reacts to weak economyQuarterly Portfolio Report & Stock Market Timing Techniques - BỘ NỘI VỤ
Ardelyx, Inc. Stock Soars 20.96%, Hits Intraday High of $6.73 - Markets Mojo
Ardelyx, Inc. (NASDAQ:ARDX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Raymond James raises Ardelyx stock price target to $15 on strong Ibsrela growth By Investing.com - Investing.com South Africa
Ardelyx (NASDAQ:ARDX) Insider Sells $35,600.04 in Stock - MarketBeat
[Form 4] ARDELYX, INC. Insider Trading Activity - Stock Titan
Ardelyx Executives Sell Shares to Cover Taxes - TradingView
Ardelyx Insider Sold Shares Worth $259,609, According to a Recent SEC Filing - marketscreener.com
Ardelyx insider Form 4 details 46,887-share RSU tax sale - Stock Titan
Officer Williams Surrenders 6,426 Of Ardelyx Inc [ARDX] - TradingView
Market Sentiment Around Loss-Making Ardelyx, Inc. (NASDAQ:ARDX) - 富途牛牛
Raymond James raises Ardelyx stock price target to $15 on strong Ibsrela growth - Investing.com
Ardelyx Inc Stock Analysis and ForecastEarnings Season Recap & Affordable Stock Picks - earlytimes.in
Ardelyx price target raised to $10 from $9 at Piper Sandler - MSN
How Ardelyx Inc. stock reacts to job market dataIndex Update & Proven Capital Preservation Methods - newser.com
Is Ardelyx Inc. (41X) stock ideal for retirement investorsMarket Activity Recap & Technical Analysis for Trade Confirmation - newser.com
Officer Williams Files To Sell 6,354 Of Ardelyx Inc [ARDX] - TradingView
Officer Reilly Files To Sell 10,845 Of Ardelyx Inc [ARDX] - TradingView
Will Ardelyx Inc. stock gain from government policiesJuly 2025 Review & AI Enhanced Trade Execution Alerts - newser.com
How Ardelyx Inc. stock valuations compare to rivalsDollar Strength & Long-Term Capital Growth Strategies - newser.com
Traders Buy Large Volume of Ardelyx Call Options (NASDAQ:ARDX) - MarketBeat
BTIG Maintains a Buy on Ardelyx, Inc (ARDX) - MSN
Combining machine learning predictions for Ardelyx Inc.July 2025 Outlook & Short-Term Trading Alerts - newser.com
What momentum indicators show for Ardelyx Inc. stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
Ardelyx Inc Azioni (ARDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ardelyx Inc Azioni (ARDX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| RAAB MICHAEL | President & CEO |
Nov 21 '25 |
Sale |
5.54 |
46,887 |
259,609 |
1,455,363 |
| Kelliher Mike | See Remarks |
Nov 21 '25 |
Sale |
5.54 |
5,560 |
30,785 |
271,181 |
| Williams Laura A | Chief Patient Officer |
Nov 21 '25 |
Sale |
5.54 |
6,426 |
35,580 |
359,896 |
| Foster Eric Duane | Chief Commercial Officer |
Nov 21 '25 |
Sale |
5.54 |
5,814 |
32,192 |
295,684 |
| Reilly Joseph James | See Remarks |
Nov 21 '25 |
Sale |
5.54 |
11,086 |
61,382 |
108,914 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):